Legend Biotech US
Principal Scientist of Immunology
Legend Biotech US, Piscataway, New Jersey, United States,
Company Information
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy.
Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.
Legend Biotech is seeking
Principal Scientist of Immunology
as part of the
R&D
team based in
Piscataway, NJ.
Role Overview
Legend Biotechnology is seeking a principal scientist to join our exploratory technology group and contribute to new technology/platform. The successful candidate should possess extensive knowledge and research experience in immunology, molecular biology and cell therapy, gene editing, in particular in vivo CART experience. The candidate should have a comprehensive understanding of T/NK cell therapy, virus packaging, and immune cell function assay. Experience with lentivirus gene therapy and in vivo CART is preferred. The candidate will be able to contribute to developing in vivo cell therapy platform through lentivirus vector design, ex vivo and in vitro function assay. 2-3 years of biotech or pharmaceutical industry experience is preferred. The candidate needs to demonstrate the ability to deliver scientific results with integrity and meet timelines, show the value of collaboration and teamwork, and provide strategy, expertise, and guidance in a fast-paced environment.
Key Responsibilities
Develop cell therapy gene editing platform and optimize cell-based immunoassays, including virus packaging, immune cell isolation and expansion, multi-color flow cytometry, ELISA, and cytotoxic assays.
Independently design and execute experiments, document and interpret scientific results, and present the data to peers.
Stay alert to industry developments and possess a good sense of new tech/platform in the field.
Deliver results and meet timelines with good communication and teamwork spirit.
Participate in lab support work.
Requirements
PhD in Immunology / Molecular Biology/Genetics, or a Master's with extensive experience.
More than 3 years' post-graduate experience in human immunology, virology or lentivector gene therapy; 2-3 years of industry experience is preferred; in vivo CART experience is a plus.
Expertise in molecular biology, vector design, gene-editing, and CART.
#J-18808-Ljbffr
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy.
Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.
Legend Biotech is seeking
Principal Scientist of Immunology
as part of the
R&D
team based in
Piscataway, NJ.
Role Overview
Legend Biotechnology is seeking a principal scientist to join our exploratory technology group and contribute to new technology/platform. The successful candidate should possess extensive knowledge and research experience in immunology, molecular biology and cell therapy, gene editing, in particular in vivo CART experience. The candidate should have a comprehensive understanding of T/NK cell therapy, virus packaging, and immune cell function assay. Experience with lentivirus gene therapy and in vivo CART is preferred. The candidate will be able to contribute to developing in vivo cell therapy platform through lentivirus vector design, ex vivo and in vitro function assay. 2-3 years of biotech or pharmaceutical industry experience is preferred. The candidate needs to demonstrate the ability to deliver scientific results with integrity and meet timelines, show the value of collaboration and teamwork, and provide strategy, expertise, and guidance in a fast-paced environment.
Key Responsibilities
Develop cell therapy gene editing platform and optimize cell-based immunoassays, including virus packaging, immune cell isolation and expansion, multi-color flow cytometry, ELISA, and cytotoxic assays.
Independently design and execute experiments, document and interpret scientific results, and present the data to peers.
Stay alert to industry developments and possess a good sense of new tech/platform in the field.
Deliver results and meet timelines with good communication and teamwork spirit.
Participate in lab support work.
Requirements
PhD in Immunology / Molecular Biology/Genetics, or a Master's with extensive experience.
More than 3 years' post-graduate experience in human immunology, virology or lentivector gene therapy; 2-3 years of industry experience is preferred; in vivo CART experience is a plus.
Expertise in molecular biology, vector design, gene-editing, and CART.
#J-18808-Ljbffr